July 21, 2016

Rhythm Announces New England Journal of Medicine Publication of Setmelanotide Phase 2 Data for Treatment of POMC Deficiency Obesity

Significant weight loss with targeted treatment for patients with rare genetic defect in critical weight regulation pathway